Evidence map›Paper›PMID 25006584›Full record

Trial reportBioMed research international2014

Evaluation of prognostic significance of circulating tumor cells detection in rectal cancer patients treated with preoperative radiotherapy: prospectively collected material data.

Dominika Nesteruk, Andrzej Rutkowski, Stanisław Fabisiewicz, Jacek Pawlak, Janusz A Siedlecki, Anna Fabisiewicz

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dominika NesterukDepartment of Molecular and Translational Oncology, The Maria Skłodowska-Curie Cancer Center and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland ; Department of Medical Genetics, Institute of Mother and Child, 01-211 Warsaw, Poland.ORCID 0000-0002-7055-3458
Andrzej RutkowskiDepartment of Oncological Gastroenterology, The Maria Skłodowska-Curie Cancer Center and Institute of Oncology, 02-781 Warsaw, Poland.
Stanisław FabisiewiczDepartment of Surgery, John Paul Western Hospital, 05-825 Grodzisk Mazowiecki, Poland.
Jacek PawlakDepartment of Surgery, John Paul Western Hospital, 05-825 Grodzisk Mazowiecki, Poland.
Janusz A SiedleckiDepartment of Molecular and Translational Oncology, The Maria Skłodowska-Curie Cancer Center and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.
Anna FabisiewiczDepartment of Molecular and Translational Oncology, The Maria Skłodowska-Curie Cancer Center and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.ORCID 0000-0002-9334-1773
The Maria Sklodowska-Curie National Research Institute of Oncology · PLJohn Paul II Hospital · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the prognostic value of circulating tumor cells (CTC) in nonmetastatic rectal cancer patients treated with short-term preoperative radiotherapy. In this single-center trial, 162 patients with rectal cancer after preoperative short-term radiotherapy (5 × 5 Gy) were recruited from January, 2008 to September, 2011. Clearance of CTC was determined in 91 patients enrolled in the molecular analysis. CTC presence was evaluated with real-time reverse transcription polymerase chain reaction assay (qPCR) based on the expression of three tumor genetic markers: carcinoembryonic antigen (CEA), cytokeratin 20 (CK20), and/or cancer stem cells marker CD133 (CEA/CK20/CD133). We found that CTC detection 7 days after surgery was of prognostic significance for the local recurrence (P value = 0.006). CTC detected preoperatively and 24 hours after resection had no prognostic value in cancer recurrence; however, there was a significant relationship between CTC prevalence 24 hours after surgery and lymph node metastasis (pN1-2). We also confirmed a significant clearance of CTC in peripheral blood (PB) 24 hours after surgery. Preoperative sampling is not significant for prognosis in rectal cancer patients treated with short-term radiotherapy. Detection of CTC in PB 7 days after surgery is an independent factor predicting local recurrence in this group of patients.

Indexed as

Preoperative CareAgedCell Line, TumorFemaleHumansMaleNeoplastic Cells, CirculatingPrognosisProspective StudiesRectal Neoplasms

Identifiers

PMID25006584
PMCPMC4070579
OpenAlexW1989437005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.